[Management of severely head-injured patients during the first 24 hours. Which specific therapeutics?].
Intracranial and systemic mechanisms of the secondary brain lesion are the targets of specific therapy for the head-injured patient. Recommendations for good clinical practice have recently defined the role of the main therapeutic measures. There is no indication for corticosteroids in head injury. Mannitol is the first-choice therapy for increased intracranial pressure, and barbiturates are still considered as a rescue therapy in case of refractory intracranial hypertension. The place of hypothermia remains to be defined. Although controversial, optimized hyperventilation, induced systemic hypertension and vasoconstrictive therapy are optimally used under multimodal monitoring. New therapeutic perspectives, aimed at controlling biochemical disorders at a cellular level, are under investigation, but are still inconclusive at the present time.
Damas
F
F
Service universitaire d'anesthésie-réanimation, CHR de la Citadelle, CHU de Liège, Belgique.
Hans
P
P
D001463:Barbiturates / Q000627:therapeutic use; D001930:Brain Injuries / Q000503:physiopathology / Q000628:therapy*; D006259:Craniocerebral Trauma / Q000503:physiopathology / Q000628:therapy*; D006801:Humans; D007036:Hypothermia, Induced; D019586:Intracranial Hypertension / Q000188:drug therapy; D008353:Mannitol / Q000627:therapeutic use
D001463:Barbiturates; D008353:Mannitol